| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/EJI.200939781 |
| P698 | PubMed publication ID | 19950182 |
| P50 | author | Elizabeth C Jury | Q91503421 |
| David A. Isenberg | Q42326409 | ||
| Michael R Ehrenstein | Q60017325 | ||
| Claudia Mauri | Q60317802 | ||
| Fabian Flores-Borja | Q63921647 | ||
| P2093 | author name string | Mark Lazarus | |
| Hardeep S Kalsi | |||
| P2860 | cites work | Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study | Q84173080 |
| Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells | Q24299640 | ||
| Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation | Q24313151 | ||
| Decreased effector memory CD45RA+ CD62L- CD8+ T cells and increased central memory CD45RA- CD62L+ CD8+ T cells in peripheral blood of rheumatoid arthritis patients | Q24804104 | ||
| CTLA-4 can function as a negative regulator of T cell activation | Q28235866 | ||
| Reversal of the TCR stop signal by CTLA-4 | Q28259985 | ||
| Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4 | Q28284177 | ||
| A native soluble form of CTLA-4 | Q28565263 | ||
| Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4 | Q29619280 | ||
| CTLA-4 control over Foxp3+ regulatory T cell function | Q29619413 | ||
| Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
| Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus | Q34574768 | ||
| Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development | Q34597933 | ||
| CTLA4 mediates antigen-specific apoptosis of human T cells | Q34735857 | ||
| Abnormal T cell signal transduction in systemic lupus erythematosus | Q34736534 | ||
| Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype | Q36059631 | ||
| T- and B-cell abnormalities in systemic lupus erythematosus | Q36161314 | ||
| Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. | Q36189566 | ||
| Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor | Q36326042 | ||
| Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation | Q36370285 | ||
| Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. | Q36370461 | ||
| Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia | Q36403785 | ||
| A molecular perspective of CTLA-4 function | Q36427322 | ||
| Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus | Q36755899 | ||
| Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity | Q36983608 | ||
| Agrin signalling contributes to cell activation and is overexpressed in T lymphocytes from lupus patients | Q37001191 | ||
| Regulatory T cells in systemic lupus erythematosus: past, present and future | Q37129619 | ||
| CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasis | Q37196273 | ||
| Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. | Q37256978 | ||
| Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus | Q37370498 | ||
| Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain | Q37380253 | ||
| Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production | Q40165347 | ||
| Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function | Q42108511 | ||
| CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases | Q43968794 | ||
| Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus | Q44929014 | ||
| Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha | Q46182117 | ||
| Decreased T cell response to anti-CD2 in systemic lupus erythematosus and reversal by anti-CD28: evidence for impaired T cell-accessory cell interaction | Q46793771 | ||
| Differential expression of CTLA-4 among T cell subsets | Q47594359 | ||
| Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus | Q47618195 | ||
| T effectors outfox T regulators in autoimmunity | Q48213336 | ||
| Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus. | Q52574763 | ||
| Clinical manifestations and analyses of the cytotoxic T-lymphocyte associated-4 gene in two Japanese families with systemic lupus erythematosus. | Q53442368 | ||
| T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor. | Q53591138 | ||
| Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity | Q56900258 | ||
| Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study | Q56901838 | ||
| Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo | Q56901901 | ||
| Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus | Q56902724 | ||
| CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis | Q56902905 | ||
| Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosus | Q56903910 | ||
| CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region | Q56904218 | ||
| A polymorphism in the human cytotoxic T-lymphocyte antigen 4 ( CTLA4) gene (exon 1 +49) alters T-cell activation | Q56904549 | ||
| CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus | Q56905656 | ||
| Expression of CTLA-4 molecule in peripheral blood T lymphocytes from patients with systemic lupus erythematosus | Q56907452 | ||
| Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis | Q56908725 | ||
| FOXP3 Identifies Regulatory CD25brightCD4+ T Cells in Rheumatic Joints | Q57349726 | ||
| Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families | Q57350796 | ||
| Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus | Q61050853 | ||
| Abnormal differentiation of memory T cells in systemic lupus erythematosus | Q79794971 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 569-78 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus | |
| P478 | volume | 40 |
| Q54372882 | Altered expression of costimulatory molecules in Behçet's disease according to clinical activity. |
| Q61800995 | Autoimmune rheumatic disease IgG has differential effects upon neutrophil integrin activation that is modulated by the endothelium |
| Q36639915 | Brief report: increased expression of a short splice variant of CTLA-4 exacerbates lupus in MRL/lpr mice |
| Q43564970 | CTLA-4 -1722T/C polymorphism and systemic lupus erythematosus susceptibility: a meta-analysis involving ten separate studies. |
| Q56891036 | Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells |
| Q26773124 | Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus |
| Q34058156 | Exhausted cytotoxic control of Epstein-Barr virus in human lupus |
| Q84580468 | FoxP3(+) T regulatory cells in oral lichen planus and its correlation with the distinct clinical appearance of the lesions |
| Q91871661 | From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions |
| Q53108913 | Imbalanced expression of dysfunctional regulatory T cells and T-helper cells relates to immunopathogenesis in polyarteritis nodosa. |
| Q38040302 | MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY. |
| Q37263163 | MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells |
| Q37623996 | Microdomains, Inflammation, and Atherosclerosis. |
| Q37524224 | Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients. |
| Q102379531 | Novel human immunomodulatory T cell receptors and their double-edged potential in autoimmunity, cardiovascular disease and cancer |
| Q40617738 | Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects |
| Q36190001 | RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities |
| Q34161972 | Reduced Expression of TCR Zeta Is Involved in the Abnormal Production of Cytokines by Peripheral T Cells of Patients with Systemic Lupus Erythematosus |
| Q37914338 | Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis |
| Q38826175 | T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases. |
| Q36361552 | T-cell inhibitors: a bench-to-bedside review |
| Q49993738 | The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis. |
Search more.